Immatics
Sabrina Schecher currently serves as Senior Director for Corporate Strategy & Communications and Investor Relations at Immatics, where responsibilities include project management of preclinical TCR-T programs and scientific communications. Previous experience includes a postdoctoral researcher role at the Institute of Pathology, University Medical Center Mainz, focusing on DNA damage in prostate cancer and managing interdisciplinary oncology projects. Sabrina's academic background encompasses a PhD in Biology from Heidelberg University and a state examination in Pharmacy from the same institution. Early research exposure includes internships at Bayer HealthCare, University Hospital Heidelberg, University of Cambridge, and Cardiff University, with a focus on cancer research and molecular biology.
This person is not in any teams
This person is not in any offices
Immatics
9 followers
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.